Life Cell Imaging Market Multiplies Its Growth Aspects As Perkinelmer Joins The Jump-Cp Consortium To Augment The Development Of The Largest Cell Imaging Database In The World
Based on region, Asia Pacific is attributing to the life cell imaging market expansion in view of the new policy measures for stem cell treatments studies in India, South Korea, and China along with the advantageous modifications in FDI (Foreign Direct Investment) legislation in this region. Likewise, the North American region is also accommodating the life cell imaging market in light of the advancement of medical research coupled with the well-established pharmaceutical industry.
Life cell imaging is the latest treatment option for premature babies to help them grow up healthily and normally with fewer problems. The technique of using an EPG allows the use of fluorescent dye in order to provide color contrast in the cells. The technique is based on the concept that cancer cells are mostly found in cells which are not colored, whereas healthy cells tend to be colored or have different shades in their nuclei. So using fluorescent dye can reveal the cancerous cells and thus enable the treatment to be more effective.
The live cell imaging market is largely driven by the increasing application of high-content screening approaches in drug development and the soaring prevalence of cancer. In June 2021, PerkinElmer announced to offer its cell painting tools to the JUMP-CP (Joint Undertaking in Morphological Profiling – Cell Painting) consortium to accelerate the drug discovery by developing the world’s largest dataset for cell painting.
The study of nuclei stained with fluorescent dye has given rise to various techniques used in the field of microscopy and biomedicine. This latest technique does not alter the basic techniques used in the field of microscopy like the use of excitation, emission, absorption, and fluorescence microscopy etc. The use of the fluorescent microscope is seen in the field of immunology, where various proteins are visualized for various functions like tumor markers and antibodies. The same technique is applied to live cell imaging to reveal the live and vital cells in the affected area. The treatment is possible in the case of patients suffering from any type of cancer; this includes breast, lung, cervical, ovarian, leukemia, pancreatic, oral, skin and Hodgkin's lymphoma cancers.
In June 2021, Nanology Labs received an investment of US$ 2.49 million in a seed-funding round for developing a polymer-lipid solution that can supply nanoparticles to human cells. Over the forthcoming years, the life cell imaging market development will be aided by increased research funding as well as increased government financing and involvement in cell therapy research. However, the hefty price of high-content screening devices, on the other hand, is restricting their broad use, hence, limiting the scope for the life cell imaging market.
Comments
Post a Comment